Skip to product information
1 of 1

GeneBio Systems

Fluor® 488 Anti-Human CD192/CCR2 Antibody[K036C2]

Fluor® 488 Anti-Human CD192/CCR2 Antibody[K036C2]

SKU:GBS-F1385L

Regular price £320.00 GBP
Regular price Sale price £320.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size:100Tests

Storage:This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Flow Cytometry Antibodies

Abbreviation:CD192;CCR2

Target Synonym:CC-CKR-2;CCR2A;CCR2B;CKR2;CKR2A;CKR2B;CMKBR2;MCP-1-R

Research Areas:Cell Adhesion;Cell Biology;Immunology;Innate Immunity;Neuroinflammation;Neuroscience

Conjugation:Elab Fluor®488

Host:Mouse

Species reactivity:Human

Application:FCM

Usage:Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.

Isotype:Mouse IgG2a, κ

Clonality:Monoclonal

Clone NO.:K036C2

UNIProt ID:P41597

Background:CCR2 is a chemokine receptor that binds monocyte chemoattractant proteins (MCP-1, 2, 3 and 4). Two spliced variants were initially described for CCR2 (CCR2A and CCR2B). These variants differ in their terminal carboxyl tails. Monocyte adhesion to the arterial endothelium and subsequent migration into the intima are central events in the pathogenesis of atherosclerosis. CCR2 and MCP-1 have been associated to atherosclerotic plaques. MCP-1 is induced by modified-LDL in endothelial cells and may trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Local overexpression of MCP-1 at vessel walls induces infiltration of macrophages and formation of atherosclerotic lesions. Obesity induces an inflammatory state that is implicated in many clinically important complications, including insulin resistance, diabetes, atherosclerosis, and non-alcoholic fatty liver disease. CCR2 influences the development of obesity and associated adipose tissue inflammation.

Concentration:

Control catalog number:E-AB-F09802L

Immunogen:

Buffer:Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.

Purification method:

Dilution:

GeneID:729230

View full details